Global Restless Legs Syndrome Market Research Report 2022

SKU ID : QYR-20704172 | Publishing Date : 12-Apr-2022 | No. of pages : 94

Request a free Sample

Detailed TOC of Global Restless Legs Syndrome Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Restless Legs Syndrome Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Pharmacological Therapy
        1.2.3 Non-Pharmacological Therapy
    1.3 Market by End User
        1.3.1 Global Restless Legs Syndrome Market Share by End User: 2017 VS 2021 VS 2028
        1.3.2 Below 35 Years Old
        1.3.3 From 35 to 50 Years Old
        1.3.4 Above 50 Years Old
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Restless Legs Syndrome Market Perspective (2017-2028)
    2.2 Restless Legs Syndrome Growth Trends by Region
        2.2.1 Restless Legs Syndrome Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Restless Legs Syndrome Historic Market Size by Region (2017-2022)
        2.2.3 Restless Legs Syndrome Forecasted Market Size by Region (2023-2028)
    2.3 Restless Legs Syndrome Market Dynamics
        2.3.1 Restless Legs Syndrome Industry Trends
        2.3.2 Restless Legs Syndrome Market Drivers
        2.3.3 Restless Legs Syndrome Market Challenges
        2.3.4 Restless Legs Syndrome Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Restless Legs Syndrome Players by Revenue
        3.1.1 Global Top Restless Legs Syndrome Players by Revenue (2017-2022)
        3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2017-2022)
    3.2 Global Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Restless Legs Syndrome Revenue
    3.4 Global Restless Legs Syndrome Market Concentration Ratio
        3.4.1 Global Restless Legs Syndrome Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Restless Legs Syndrome Revenue in 2021
    3.5 Restless Legs Syndrome Key Players Head office and Area Served
    3.6 Key Players Restless Legs Syndrome Product Solution and Service
    3.7 Date of Enter into Restless Legs Syndrome Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Restless Legs Syndrome Breakdown Data by Type
    4.1 Global Restless Legs Syndrome Historic Market Size by Type (2017-2022)
    4.2 Global Restless Legs Syndrome Forecasted Market Size by Type (2023-2028)
5 Restless Legs Syndrome Breakdown Data by End User
    5.1 Global Restless Legs Syndrome Historic Market Size by End User (2017-2022)
    5.2 Global Restless Legs Syndrome Forecasted Market Size by End User (2023-2028)
6 North America
    6.1 North America Restless Legs Syndrome Market Size (2017-2028)
    6.2 North America Restless Legs Syndrome Market Size by Country (2017-2022)
    6.3 North America Restless Legs Syndrome Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Restless Legs Syndrome Market Size (2017-2028)
    7.2 Europe Restless Legs Syndrome Market Size by Country (2017-2022)
    7.3 Europe Restless Legs Syndrome Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Restless Legs Syndrome Market Size (2017-2028)
    8.2 Asia-Pacific Restless Legs Syndrome Market Size by Country (2017-2022)
    8.3 Asia-Pacific Restless Legs Syndrome Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Restless Legs Syndrome Market Size (2017-2028)
    9.2 Latin America Restless Legs Syndrome Market Size by Country (2017-2022)
    9.3 Latin America Restless Legs Syndrome Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Restless Legs Syndrome Market Size (2017-2028)
    10.2 Middle East & Africa Restless Legs Syndrome Market Size by Country (2017-2022)
    10.3 Middle East & Africa Restless Legs Syndrome Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Boehringer Ingelheim GmbH
        11.1.1 Boehringer Ingelheim GmbH Company Detail
        11.1.2 Boehringer Ingelheim GmbH Business Overview
        11.1.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Introduction
        11.1.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2017-2022)
        11.1.5 Boehringer Ingelheim GmbH Recent Development
    11.2 UCB SA
        11.2.1 UCB SA Company Detail
        11.2.2 UCB SA Business Overview
        11.2.3 UCB SA Restless Legs Syndrome Introduction
        11.2.4 UCB SA Revenue in Restless Legs Syndrome Business (2017-2022)
        11.2.5 UCB SA Recent Development
    11.3 Astellas
        11.3.1 Astellas Company Detail
        11.3.2 Astellas Business Overview
        11.3.3 Astellas Restless Legs Syndrome Introduction
        11.3.4 Astellas Revenue in Restless Legs Syndrome Business (2017-2022)
        11.3.5 Astellas Recent Development
    11.4 Arbor Pharmaceuticals
        11.4.1 Arbor Pharmaceuticals Company Detail
        11.4.2 Arbor Pharmaceuticals Business Overview
        11.4.3 Arbor Pharmaceuticals Restless Legs Syndrome Introduction
        11.4.4 Arbor Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022)
        11.4.5 Arbor Pharmaceuticals Recent Development
    11.5 GlaxoSmithKline plc.
        11.5.1 GlaxoSmithKline plc. Company Detail
        11.5.2 GlaxoSmithKline plc. Business Overview
        11.5.3 GlaxoSmithKline plc. Restless Legs Syndrome Introduction
        11.5.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2017-2022)
        11.5.5 GlaxoSmithKline plc. Recent Development
    11.6 Ligand Pharmaceuticals Incorporated
        11.6.1 Ligand Pharmaceuticals Incorporated Company Detail
        11.6.2 Ligand Pharmaceuticals Incorporated Business Overview
        11.6.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Introduction
        11.6.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2017-2022)
        11.6.5 Ligand Pharmaceuticals Incorporated Recent Development
    11.7 axxonis Pharma AG
        11.7.1 axxonis Pharma AG Company Detail
        11.7.2 axxonis Pharma AG Business Overview
        11.7.3 axxonis Pharma AG Restless Legs Syndrome Introduction
        11.7.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2017-2022)
        11.7.5 axxonis Pharma AG Recent Development
    11.8 Kyowa Hakko Kirin Co.
        11.8.1 Kyowa Hakko Kirin Co. Company Detail
        11.8.2 Kyowa Hakko Kirin Co. Business Overview
        11.8.3 Kyowa Hakko Kirin Co. Restless Legs Syndrome Introduction
        11.8.4 Kyowa Hakko Kirin Co. Revenue in Restless Legs Syndrome Business (2017-2022)
        11.8.5 Kyowa Hakko Kirin Co. Recent Development
    11.9 Jazz Pharmaceuticals, Inc.
        11.9.1 Jazz Pharmaceuticals, Inc. Company Detail
        11.9.2 Jazz Pharmaceuticals, Inc. Business Overview
        11.9.3 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Introduction
        11.9.4 Jazz Pharmaceuticals, Inc. Revenue in Restless Legs Syndrome Business (2017-2022)
        11.9.5 Jazz Pharmaceuticals, Inc. Recent Development
    11.10 Omeros Corporation
        11.10.1 Omeros Corporation Company Detail
        11.10.2 Omeros Corporation Business Overview
        11.10.3 Omeros Corporation Restless Legs Syndrome Introduction
        11.10.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2017-2022)
        11.10.5 Omeros Corporation Recent Development
    11.11 Manhattan Pharmaceuticals
        11.11.1 Manhattan Pharmaceuticals Company Detail
        11.11.2 Manhattan Pharmaceuticals Business Overview
        11.11.3 Manhattan Pharmaceuticals Restless Legs Syndrome Introduction
        11.11.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022)
        11.11.5 Manhattan Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Restless Legs Syndrome Market Research Report 2022

List of Tables
    Table 1. Global Restless Legs Syndrome Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Pharmacological Therapy
    Table 3. Key Players of Non-Pharmacological Therapy
    Table 4. Global Restless Legs Syndrome Market Size Growth by End User (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Restless Legs Syndrome Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Restless Legs Syndrome Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Restless Legs Syndrome Market Share by Region (2017-2022)
    Table 8. Global Restless Legs Syndrome Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Restless Legs Syndrome Market Share by Region (2023-2028)
    Table 10. Restless Legs Syndrome Market Trends
    Table 11. Restless Legs Syndrome Market Drivers
    Table 12. Restless Legs Syndrome Market Challenges
    Table 13. Restless Legs Syndrome Market Restraints
    Table 14. Global Restless Legs Syndrome Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Restless Legs Syndrome Market Share by Players (2017-2022)
    Table 16. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2021)
    Table 17. Ranking of Global Top Restless Legs Syndrome Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Restless Legs Syndrome Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Restless Legs Syndrome Product Solution and Service
    Table 21. Date of Enter into Restless Legs Syndrome Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Restless Legs Syndrome Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Restless Legs Syndrome Revenue Market Share by Type (2017-2022)
    Table 25. Global Restless Legs Syndrome Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Restless Legs Syndrome Revenue Market Share by Type (2023-2028)
    Table 27. Global Restless Legs Syndrome Market Size by End User (2017-2022) & (US$ Million)
    Table 28. Global Restless Legs Syndrome Revenue Market Share by End User (2017-2022)
    Table 29. Global Restless Legs Syndrome Forecasted Market Size by End User (2023-2028) & (US$ Million)
    Table 30. Global Restless Legs Syndrome Revenue Market Share by End User (2023-2028)
    Table 31. North America Restless Legs Syndrome Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Restless Legs Syndrome Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Restless Legs Syndrome Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Restless Legs Syndrome Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Restless Legs Syndrome Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Restless Legs Syndrome Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Restless Legs Syndrome Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Restless Legs Syndrome Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Restless Legs Syndrome Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Restless Legs Syndrome Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Boehringer Ingelheim GmbH Company Detail
    Table 42. Boehringer Ingelheim GmbH Business Overview
    Table 43. Boehringer Ingelheim GmbH Restless Legs Syndrome Product
    Table 44. Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 45. Boehringer Ingelheim GmbH Recent Development
    Table 46. UCB SA Company Detail
    Table 47. UCB SA Business Overview
    Table 48. UCB SA Restless Legs Syndrome Product
    Table 49. UCB SA Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 50. UCB SA Recent Development
    Table 51. Astellas Company Detail
    Table 52. Astellas Business Overview
    Table 53. Astellas Restless Legs Syndrome Product
    Table 54. Astellas Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 55. Astellas Recent Development
    Table 56. Arbor Pharmaceuticals Company Detail
    Table 57. Arbor Pharmaceuticals Business Overview
    Table 58. Arbor Pharmaceuticals Restless Legs Syndrome Product
    Table 59. Arbor Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 60. Arbor Pharmaceuticals Recent Development
    Table 61. GlaxoSmithKline plc. Company Detail
    Table 62. GlaxoSmithKline plc. Business Overview
    Table 63. GlaxoSmithKline plc. Restless Legs Syndrome Product
    Table 64. GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 65. GlaxoSmithKline plc. Recent Development
    Table 66. Ligand Pharmaceuticals Incorporated Company Detail
    Table 67. Ligand Pharmaceuticals Incorporated Business Overview
    Table 68. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product
    Table 69. Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 70. Ligand Pharmaceuticals Incorporated Recent Development
    Table 71. axxonis Pharma AG Company Detail
    Table 72. axxonis Pharma AG Business Overview
    Table 73. axxonis Pharma AG Restless Legs Syndrome Product
    Table 74. axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 75. axxonis Pharma AG Recent Development
    Table 76. Kyowa Hakko Kirin Co. Company Detail
    Table 77. Kyowa Hakko Kirin Co. Business Overview
    Table 78. Kyowa Hakko Kirin Co. Restless Legs Syndrome Product
    Table 79. Kyowa Hakko Kirin Co. Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 80. Kyowa Hakko Kirin Co. Recent Development
    Table 81. Jazz Pharmaceuticals, Inc. Company Detail
    Table 82. Jazz Pharmaceuticals, Inc. Business Overview
    Table 83. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product
    Table 84. Jazz Pharmaceuticals, Inc. Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 85. Jazz Pharmaceuticals, Inc. Recent Development
    Table 86. Omeros Corporation Company Detail
    Table 87. Omeros Corporation Business Overview
    Table 88. Omeros Corporation Restless Legs Syndrome Product
    Table 89. Omeros Corporation Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 90. Omeros Corporation Recent Development
    Table 91. Manhattan Pharmaceuticals Company Detail
    Table 92. Manhattan Pharmaceuticals Business Overview
    Table 93. Manhattan Pharmaceuticals Restless Legs SyndromeProduct
    Table 94. Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 95. Manhattan Pharmaceuticals Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Restless Legs Syndrome Market Share by Type: 2021 VS 2028
    Figure 2. Pharmacological Therapy Features
    Figure 3. Non-Pharmacological Therapy Features
    Figure 4. Global Restless Legs Syndrome Market Share by End User in 2021 & 2028
    Figure 5. Below 35 Years Old Case Studies
    Figure 6. From 35 to 50 Years Old Case Studies
    Figure 7. Above 50 Years Old Case Studies
    Figure 8. Restless Legs Syndrome Report Years Considered
    Figure 9. Global Restless Legs Syndrome Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Restless Legs Syndrome Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Restless Legs Syndrome Market Share by Region: 2021 VS 2028
    Figure 12. Global Restless Legs Syndrome Market Share by Players in 2021
    Figure 13. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Restless Legs Syndrome Revenue in 2021
    Figure 15. North America Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Restless Legs Syndrome Market Share by Country (2017-2028)
    Figure 17. United States Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Restless Legs Syndrome Market Share by Country (2017-2028)
    Figure 21. Germany Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Restless Legs Syndrome Market Share by Region (2017-2028)
    Figure 29. China Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Restless Legs Syndrome Market Share by Country (2017-2028)
    Figure 37. Mexico Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Restless Legs Syndrome Market Share by Country (2017-2028)
    Figure 41. Turkey Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 44. UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 45. Astellas Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 46. Arbor Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 47. GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 48. Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 49. axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 50. Kyowa Hakko Kirin Co. Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 51. Jazz Pharmaceuticals, Inc. Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 52. Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 53. Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed

Keyplayers in Global Restless Legs Syndrome Market Research Report 2022

Boehringer Ingelheim GmbH
UCB SA
Astellas
Arbor Pharmaceuticals
GlaxoSmithKline plc.
Ligand Pharmaceuticals Incorporated
axxonis Pharma AG
Kyowa Hakko Kirin Co.
Jazz Pharmaceuticals, Inc.
Omeros Corporation
Manhattan Pharmaceuticals